CoV-2, discovered in China's Wuhan Institute of Virology, raises concerns due to its potential to infect human cells ...

UMass Chan Medical School is partnering with Curai Health to provide virtual care to participants enrolled in a study investigating how at-home antigen and molecular tests compare to lab-based PCR ...

The results of this study suggest that mRNA COVID-19 vaccination may be a protective factor against post–COVID-19 condition ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

CoV-2, the HKU5-CoV-2 virus's ability to infect humans has raised alarm over the potential of another pandemic, Fox News reports. Other outbreaks in the news include bird flu, seasonal flu, listeria, ...

CoV-2, has been discovered in China. This virus can bind to the same human receptor (ACE2) as the COVID-19 virus, which ...

In the early, uncertain days of the coronavirus pandemic, scientists delivered one comforting pronouncement: The virus that ...

Clinical trials planned to begin patient enrollment during 2025 to evaluate Gylden’s T cell Priming (TcP) candidates against Dengue (Phase II) ...

Scientists explored the differences in heart inflammation caused by COVID-19, anti-COVID-19 vaccines, and other viral ...

Pew Research Center conducted a survey to gauge Americans’ views on the current COVID risk and how the pandemic was handled.

CoV-2, found in China has sparked concerns among health officials and has triggered panic. HKU5-CoV-2 has similarities to the ...

The incidence of post-COVID-19 condition (also known as long COVID) has been estimated at 6–40%, in which patients have at ...